.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Novartis
Accenture
Colorcon
Teva
Merck
Cerilliant
Citi
Julphar

Generated: June 22, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Acs Dobfar

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
8852III11/21/1990ACS DOBFAR SPA7-AMINO-3-CHLORO CEPHEM ESTER
9876III9/22/1992ACS DOBFAR SPAO-FORMYL CEFAMANDOLE ACETONITRILE SOLVATE
10003AII11/25/1992ACS DOBFAR SPASODIUM CARBONATE STERILE
10076IV12/18/1986ACS DOBFAR SPASTERILE FINISHED PRODUCTS AND STERILE PROCESSING OPERATIONS AT THE VIALE ADDETTA PLANT IN MILANO, ITALY
10077AV8/27/1991ACS DOBFAR SPASTERILE FINISHED PRODUCTS AND STERILE PROCESSING OPERATIONS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Healthtrust
US Department of Justice
Fuji
QuintilesIMS
Novartis
Chinese Patent Office
Cantor Fitzgerald
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot